225 related articles for article (PubMed ID: 26611245)
1. Oxymetazoline Applied Topically to the Nasal Mucosa Decreases Trans-Mucosal Nitrous Oxide Exchange for the Middle Ear.
Teixeira MS; Alper CM; Martin BS; Helal N; Doyle BM; Doyle WJ
Ann Otol Rhinol Laryngol; 2016 May; 125(5):400-7. PubMed ID: 26611245
[TBL] [Abstract][Full Text] [Related]
2. Histamine Applied Topically to the Nasal Mucosa Increases the Transmucosal Nitrous Oxide Exchange for the Middle Ear.
Teixeira MS; Alper CM; Martin BS; Cetin S; El-Wagaa JA; Doyle WJ
Ann Otol Rhinol Laryngol; 2017 Apr; 126(4):284-289. PubMed ID: 28103698
[TBL] [Abstract][Full Text] [Related]
3. Oral pseudoephedrine decreases the rate of transmucosal nitrous oxide exchange for the middle ear.
Teixeira MS; Alper CM; Martin BS; Doyle BM; Doyle WJ
Laryngoscope; 2015 Sep; 125(9):2181-6. PubMed ID: 26152838
[TBL] [Abstract][Full Text] [Related]
4. Nasal prostaglandin challenge increases N2O exchange from blood to middle ear.
Yuksel S; Doyle WJ; Banks J; Seroky JT; Alper CM
Auris Nasus Larynx; 2005 Mar; 32(1):29-32. PubMed ID: 15882822
[TBL] [Abstract][Full Text] [Related]
5. A double-blind comparison between oral pseudoephedrine and topical oxymetazoline in the prevention of barotrauma during air travel.
Jones JS; Sheffield W; White LJ; Bloom MA
Am J Emerg Med; 1998 May; 16(3):262-4. PubMed ID: 9596428
[TBL] [Abstract][Full Text] [Related]
6. Oxymetazoline nasal spray three times daily for four weeks in normal subjects is not associated with rebound congestion or tachyphylaxis.
Watanabe H; Foo TH; Djazaeri B; Duncombe P; Mackay IS; Durham SR
Rhinology; 2003 Sep; 41(3):167-74. PubMed ID: 14579657
[TBL] [Abstract][Full Text] [Related]
7. The effects of oxymetazoline on lysozyme secretion from the human nasal mucosa.
Browning S; Housley D; Richards R; Eccles R
Acta Otolaryngol; 1997 Nov; 117(6):851-5. PubMed ID: 9442826
[TBL] [Abstract][Full Text] [Related]
8. The nasal airways response in normal subjects to oxymetazoline spray: randomized double-blind placebo-controlled trial.
Bickford L; Shakib S; Taverner D
Br J Clin Pharmacol; 1999 Jul; 48(1):53-6. PubMed ID: 10383560
[TBL] [Abstract][Full Text] [Related]
9. Effect on the nasal mucosa of long-term treatment with oxymetazoline, benzalkonium chloride, and placebo nasal sprays.
Graf P; Hallén H
Laryngoscope; 1996 May; 106(5 Pt 1):605-9. PubMed ID: 8628089
[TBL] [Abstract][Full Text] [Related]
10. Combined intranasal ipratropium bromide and oxymetazoline in experimental rhinovirus infection.
Pitkäranta A; Wecker MT; Korts DC; Hayden FG
Am J Rhinol; 1998; 12(2):125-9. PubMed ID: 9578931
[TBL] [Abstract][Full Text] [Related]
11. Gas exchange across the middle ear mucosa in monkeys. Estimation of exchange rate.
Doyle WJ; Seroky JT; Alper CM
Arch Otolaryngol Head Neck Surg; 1995 Aug; 121(8):887-92. PubMed ID: 7619416
[TBL] [Abstract][Full Text] [Related]
12. Directional asymmetry in the measured nitrous oxide time constant for middle ear transmucosal gas exchange.
Doyle WJ; Yuksel S; Banks J; Alper CM
Ann Otol Rhinol Laryngol; 2007 Jan; 116(1):69-75. PubMed ID: 17305281
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of allergen-evoked nasal responses by local pretreatment with exogenous neuropeptide Y in atopic patients.
Lacroix JS; Mosimann BL
J Allergy Clin Immunol; 1996 Sep; 98(3):611-6. PubMed ID: 8828539
[TBL] [Abstract][Full Text] [Related]
14. One-week use of oxymetazoline nasal spray in patients with rhinitis medicamentosa 1 year after treatment.
Graf P; Hallén H
ORL J Otorhinolaryngol Relat Spec; 1997; 59(1):39-44. PubMed ID: 9104748
[TBL] [Abstract][Full Text] [Related]
15. Effects of topical nasal decongestants on histology of nasal respiratory mucosa in rabbits.
Suh SH; Chon KM; Min YG; Jeong CH; Hong SH
Acta Otolaryngol; 1995 Sep; 115(5):664-71. PubMed ID: 8928640
[TBL] [Abstract][Full Text] [Related]
16. Benzalkonium chloride in nasal decongestive sprays has a long-lasting adverse effect on the nasal mucosa of healthy volunteers.
Hallén H; Graf P
Clin Exp Allergy; 1995 May; 25(5):401-5. PubMed ID: 7553242
[TBL] [Abstract][Full Text] [Related]
17. A comparative analysis of the decongestive effect of oxymetazoline and xylometazoline in healthy subjects.
Eskiizmir G; Hirçin Z; Ozyurt B; Unlü H
Eur J Clin Pharmacol; 2011 Jan; 67(1):19-23. PubMed ID: 21069518
[TBL] [Abstract][Full Text] [Related]
18. Topical nasal decongestant oxymetazoline (0.05%) provides relief of nasal symptoms for 12 hours.
Druce HM; Ramsey DL; Karnati S; Carr AN
Rhinology; 2018 Dec; 56(4):343-350. PubMed ID: 29785414
[TBL] [Abstract][Full Text] [Related]
19. Effect of micronized cellulose powder on the efficacy of topical oxymetazoline in allergic rhinitis.
Valerieva A; Popov TA; Staevska M; Kralimarkova T; Petkova E; Valerieva E; Mustakov T; Lazarova T; Dimitrov V; Church MK
Allergy Asthma Proc; 2015; 36(6):e134-9. PubMed ID: 26133030
[TBL] [Abstract][Full Text] [Related]
20. Effect of Intranasal Vasoconstrictors on Blood Pressure: A Randomized, Double-Blind, Placebo-Controlled Trial.
Bellew SD; Johnson KL; Nichols MD; Kummer T
J Emerg Med; 2018 Oct; 55(4):455-464. PubMed ID: 30195946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
